UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005374
Receipt number R000006378
Scientific Title Combinational effect of clenbuterol chloride and anticholinergic drugs on female stress and mixed urinary incontinence
Date of disclosure of the study information 2011/04/04
Last modified on 2011/04/04 15:05:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Combinational effect of clenbuterol chloride and anticholinergic drugs on female stress and mixed urinary incontinence

Acronym

Combinational effect of clenbuterol chloride and anticholinergic drugs on female stress and mixed urinary incontinence

Scientific Title

Combinational effect of clenbuterol chloride and anticholinergic drugs on female stress and mixed urinary incontinence

Scientific Title:Acronym

Combinational effect of clenbuterol chloride and anticholinergic drugs on female stress and mixed urinary incontinence

Region

Japan


Condition

Condition

female stress and mixed urinary incontinence

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Combinational effect of clenbuterol chloride and anticholinergic drugs on female stress and mixed urinary incontinence

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

question

Key secondary outcomes

record of urination


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Behavior,custom

Interventions/Control_1

anticholinergic drugs

Interventions/Control_2

anticholinergic drugs and clenbuterol chloride

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

female stress and mixed urinary incontinence

Key exclusion criteria

.urinary incontinence
.polyuria
.severe chronic constipation
.pregnant woman
.the lactation period
.contraindication for the two drugs

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name ISHIKO OSAMU

Organization

osaka city university medical hospital

Division name

obsterictis and gynecology

Zip code


Address

1-5-7asahimachi abenoku osaka

TEL

06-6645-3862

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

osaka city university medical hospital

Division name

obsterictis and gynecology

Zip code


Address


TEL

06-6645-3862

Homepage URL


Email



Sponsor or person

Institute

osaka city university graduate school of medicine, obsterictis and gynecology

Institute

Department

Personal name



Funding Source

Organization

osaka city university graduate school of medicine, obsterictis and gynecology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪市立大学医学部付属病院


Other administrative information

Date of disclosure of the study information

2011 Year 04 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2011 Year 04 Month 04 Day

Date of IRB


Anticipated trial start date

2011 Year 04 Month 01 Day

Last follow-up date

2013 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 04 Month 04 Day

Last modified on

2011 Year 04 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006378